Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
4
currently held
Exits tracked
2
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin6 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Deallus MED I | ARCHIMED | 2015 | 9yr | Exited 2024 | GlobalData Plc | – | |||
Cobra Biologics Flerie Invest | Flerie | 2011 | 9yr | Exited 2020 | Cognate BioServices | – | |||
Millicent Pharma Limited Carlyle Global Infrastructure Opportunity Fund | The Carlyle Group | – | – | Active | – | – | |||
Theramex2 periods PAI Europe VII | PAI Partners | 2022 | 4yr | Active | – | – | |||
Advanz Pharma Nordic Capital Fund X | Nordic Capital | 2021 | 5yr | Active | – | – | |||
Dechra Pharmaceuticals EQT X | EQT | 2024 | 2yr | Active | – | – |
Deallus
MED I
United KingdomSector
Pharma
InvestorARCHIMED
Entry
2015
Hold
9yr
Exit
2024
to GlobalData Plc
Cobra Biologics
Flerie Invest
United KingdomSector
Pharma
InvestorFlerie
Entry
2011
Hold
9yr
Exit
2020
to Cognate BioServices
Millicent Pharma Limited
Carlyle Global Infrastructure Opportunity Fund
United KingdomSector
Pharma
InvestorThe Carlyle Group
Entry
–
Theramex
PAI Europe VII
United KingdomSector
Pharma
InvestorPAI Partners
Entry
2022
Hold
4yr
Owners
2
Advanz Pharma
Nordic Capital Fund X
United KingdomSector
Pharma
InvestorNordic Capital
Entry
2021
Hold
5yr
Dechra Pharmaceuticals
EQT X
United KingdomSector
Pharma
InvestorEQT
Entry
2024
Hold
2yr